|4Feb 4, 4:20 PM ET

Furey Raymond J. 4

4 · RIGEL PHARMACEUTICALS INC · Filed Feb 4, 2026

Research Summary

AI-generated summary of this filing

Updated

Rigel EVP Raymond Furey Surrenders 3,968 Shares for Tax Withholding

What Happened

  • Raymond J. Furey, EVP, General Counsel, Chief Compliance Officer and Corporate Secretary of Rigel Pharmaceuticals (RIGL), disposed of 3,968 shares on Feb 2, 2026 to satisfy a tax or exercise-related obligation (transaction code F). The shares were recorded at $36.01 each for a total value of $142,888. This was a withholding/disposition to cover taxes or exercise costs—not an open-market sale.

Key Details

  • Transaction date: 2026-02-02; Filing date: 2026-02-04 (filed within the typical 2-business-day Form 4 window).
  • Transaction type/code: F — payment of exercise price or tax liability (shares disposed to cover tax/option obligations).
  • Price per share: $36.01; Total value: $142,888.
  • Shares owned after transaction: Not disclosed in the filing.
  • Footnote: Includes 1,000 shares acquired under the issuer's stock purchase plan.
  • Not marked late (no L code); appears to be a routine withholding transaction.

Context

  • Code F transactions typically reflect shares surrendered or withheld to satisfy tax withholding or exercise costs (often part of option exercises or plan settlements). Because these are internal withholding actions rather than open-market sales or purchases, they are generally routine and do not necessarily indicate a change in the insider’s view of the company.

Insider Transaction Report

Form 4
Period: 2026-02-02
Furey Raymond J.
EVP, GC, CCO & Corp Sec
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-02-02$36.01/sh3,968$142,88835,862 total
Footnotes (1)
  • [F1]Includes 1,000 shares acquired under the Issuer's stock purchase plan.
Signature
/s/ Raymond Furey|2026-02-04

Documents

1 file
  • 4
    form4.xmlPrimary